| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/16/2013 | US20130121913 Anti-CD19 Antibodies |
| 05/16/2013 | CA2856149A1 Methods of treating inflammatory disorders using anti-m-csf antibodies |
| 05/16/2013 | CA2855669A1 Compositions and methods for treating alzheimer's disease |
| 05/16/2013 | CA2855666A1 Combination of kinase inhibitors and uses thereof |
| 05/16/2013 | CA2855252A1 Influenza virus -like particles (vlps) comprising hemagglutinin produced nicotiana tabacum |
| 05/16/2013 | CA2855224A1 Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use |
| 05/16/2013 | CA2855174A1 Antibody molecules having specificity for human ox40 |
| 05/16/2013 | CA2855155A1 Treatment of hematologic malignancies with an anti-cxcr4 antibody |
| 05/16/2013 | CA2854934A1 Carrier molecule comprising a spr0096 and a spr2021 antigen |
| 05/16/2013 | CA2854817A1 Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| 05/16/2013 | CA2854806A1 Multispecific and multivalent binding proteins and uses thereof |
| 05/16/2013 | CA2854563A1 Provasopressin antagonists and uses thereof |
| 05/16/2013 | CA2854467A1 Antagonists for abnormal vasopressin v2 receptor and uses thereof |
| 05/16/2013 | CA2854372A1 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging |
| 05/16/2013 | CA2853894A1 Film packaging for oral biologics |
| 05/16/2013 | CA2853836A1 Methods of inhibiting tumor growth by antagonizing il-6 receptor |
| 05/16/2013 | CA2852127A1 Combination drug therapy for the treatment of solid tumors |
| 05/16/2013 | CA2840900A1 Composition for prevention or treatment of ischemic cardiac disease,comprising inhibitor against age-albumin synthesis or release of mononuclearphagocyte system cells as active ingredient |
| 05/15/2013 | EP2592094A1 Binding members for IgE molecules |
| 05/15/2013 | EP2592093A1 Human c-fms antigen binding proteins |
| 05/15/2013 | EP2591822A1 Treatment of diseases |
| 05/15/2013 | EP2591802A1 Vaccine compositions based on sticholysin encapsulated in liposomes |
| 05/15/2013 | EP2591801A1 Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions |
| 05/15/2013 | EP2591800A1 Herpes simplex virus combined subunit vaccines and methods of use thereof |
| 05/15/2013 | EP2591799A1 Cancer peptide vaccine |
| 05/15/2013 | EP2591798A1 Vaccine for tumor immunotherapy |
| 05/15/2013 | EP2591796A1 Combination medicament comprising IL-12 and an anti-CTLA-4 ligand for tumor therapy |
| 05/15/2013 | EP2591793A2 Treatment of autoimmune disease |
| 05/15/2013 | EP2591786A1 Immunomodulating compositions and uses therefor |
| 05/15/2013 | EP2591771A1 Preservation of bioactive materials by freeze dried foam |
| 05/15/2013 | EP2591114A2 Immunisation of large mammals with low doses of rna |
| 05/15/2013 | EP2591108A1 A RECOMBINANT VACCINE AGAINST CLOSTRIDIUM PERFRINGENS INFECTION AND EPSILON (e ) TOXIN INTOXICATION |
| 05/15/2013 | EP2591090A2 Ceramide-like glycolipid-associated bacterial vaccines and uses thereof |
| 05/15/2013 | EP2591003A1 Cancer therapy using cldn6 target-directed antibodies in vivo |
| 05/15/2013 | EP2590994A1 Vaccine against streptococcal infections based on recombinant proteins |
| 05/15/2013 | EP2590676A2 Virion-like delivery particles for self-replicating rna molecules |
| 05/15/2013 | EP2590675A1 Respiratory syncytial virus antigenic compositions and methods |
| 05/15/2013 | EP2590674A2 Compositions and methods for treating influenza |
| 05/15/2013 | EP2590673A1 Designer peptide-based pcv2 vaccine |
| 05/15/2013 | EP2590672A2 Combinations of anti-s1p antibodies and sphingolipid pathway inhibitors |
| 05/15/2013 | EP2590671A2 Dual variable domain immunoglobulins and uses thereof |
| 05/15/2013 | EP2590670A2 Methods of raising an immune response by delivery of rna |
| 05/15/2013 | EP2590668A2 Factor ix polypeptides and methods of use thereof |
| 05/15/2013 | EP2590654A1 Combinations of kinase inhibitors for the treatment of cancer |
| 05/15/2013 | EP2590626A1 Liposomes with lipids having an advantageous pka- value for rna delivery |
| 05/15/2013 | EP2590625A2 Cationic oil-in-water emulsions |
| 05/15/2013 | EP2127652B1 Method for treating cancer using anticancer agent in combination |
| 05/15/2013 | CN1984679B Methods for preparing immunogenic conjugates |
| 05/15/2013 | CN1665528B Adjuvant viral particle |
| 05/15/2013 | CN103108886A Anti-IL-23 heterodimer specific antibodies |
| 05/15/2013 | CN103108883A Novel allergen |
| 05/15/2013 | CN103108658A Antibody formulations |
| 05/15/2013 | CN103108656A Stabilized formulations containing anti-NGF antibodies |
| 05/15/2013 | CN103108655A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| 05/15/2013 | CN103108654A Multivalent glycopeptide constructs and uses thereof |
| 05/15/2013 | CN103108653A Designer peptide-based pcv2 vaccine |
| 05/15/2013 | CN103108652A Chimeric ospa genes,proteins, and methods of use thereof |
| 05/15/2013 | CN103108650A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
| 05/15/2013 | CN103108649A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 05/15/2013 | CN103103264A Application of SMOC2 gene in preparation of medicine for detecting or treating endometrial cancer and ovarian cancer |
| 05/15/2013 | CN103103205A Gene for encoding recombinant porcine circovirus type 2 (PCV2) Cap protein and application of gene |
| 05/15/2013 | CN103103163A Lentogenic CH60 strain of duck virual hepatitis virus and attenuated live vaccine thereof |
| 05/15/2013 | CN103102412A Humanized anti-nasopharyngeal-cancer LMP2A extracellular region antibody Fab and application thereof |
| 05/15/2013 | CN103102394A B cell epitope peptide PUHI49 for hepatitis c virus (HCV) and application of B cell epitope peptide PUHI49 |
| 05/15/2013 | CN103102392A N-terminal polypeptide of retinoic acid induced protein 16 and preparation method and application of antibody thereof |
| 05/15/2013 | CN103100084A Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 05/15/2013 | CN103100083A Vaccine and preparation method thereof |
| 05/15/2013 | CN103100082A Method for preparing porcine circovirus type 2 inactivated vaccine by utilizing bioreactor |
| 05/15/2013 | CN103100081A Multi-valence combined vaccine |
| 05/15/2013 | CN102643822B Heartworm nucleic acid vaccine and method for preparing same |
| 05/15/2013 | CN102209530B Orally administrable immunostimulant product for aquaculture |
| 05/15/2013 | CN101946003B Anti-adam-15 antibodies and utilization of the same |
| 05/15/2013 | CN101374550B Strain independent amplification of pathogens and vaccines thereto |
| 05/15/2013 | CN101255195B Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 05/14/2013 | US8440402 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 05/14/2013 | US8440208 Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease |
| 05/14/2013 | US8440207 Live bacterial vaccines for viral infection prophylaxis or treatment |
| 05/14/2013 | US8440206 Methods for producing an immune response to tuberculosis |
| 05/14/2013 | US8440205 Streptococcal C5A peptidase vaccine |
| 05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
| 05/14/2013 | US8440203 Methods of immunizing pregnant heifers at three months of gestation |
| 05/14/2013 | US8440202 Induction of an immune response against dengue virus using the prime-boost approach |
| 05/14/2013 | US8440200 Using hypoallergenic peptide comprising Phl p 6 molecule to desensitize mammalian allergic response to pollen |
| 05/14/2013 | US8440199 Methods for mobilizing mesenchymal stem cells in a patient |
| 05/14/2013 | US8440198 Compositions and methods for wound healing |
| 05/14/2013 | US8440197 KID3 and KID3 antibodies that bind thereto |
| 05/14/2013 | US8440195 Inhibition of CD69 for treatment of inflammatory conditions |
| 05/14/2013 | US8440194 Angiogenesis inhibitors; immunomodulators; side effect reduction |
| 05/14/2013 | US8440193 Method for inhibiting bone resorption |
| 05/14/2013 | US8440192 Bispecific binding agents for modulating biological activity |
| 05/14/2013 | US8440191 Clearance of abnormal IGA1 in IGA1 deposition diseases |
| 05/14/2013 | US8440190 Antibody variants |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | US8440188 Therapeutic and diagnostic anti-HSP70 antibodies |
| 05/14/2013 | US8440187 Use application of sugar chain-recognizing receptor |
| 05/14/2013 | US8440186 P2X7 epitopes |
| 05/14/2013 | US8440185 Herpesvirus entry mediator (HVEM) specific immunoglobulin for use in treatment and prevention of transplant rejection, graft-versus-host and transplant autoimmune diseases |
| 05/14/2013 | US8440167 Multimodal imaging of atherosclerotic plaque targeted to LOX-1 |
| 05/14/2013 | CA2694495C Capsule composition for use as immunogen against campylobacter jejuni |
| 05/14/2013 | CA2579353C Therapeutic strategy for treating autoimmune and degenerative diseases |